A dose-dependent role for EBF1 in repressing non-B-cell-specific genes

European Journal of Immunology

Volumn 41, Issue 6, 2011, Pages 1787-1793

  Lukin, Kara ^a   Fields, Scott ^a   Guerrettaz, Lisa ^a   Straign, Desiree ^a   Rodriguez, Valerie ^a   Zandi, Sasan ^b   Månsson, Robert ^c   Cambier, John C ^a   Sigvardsson, Mikael ^b,c   Hagman, James ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Lund Strategic Research Center for Stem Cell Biology and Cell Therapy   (Sweden)

Author keywords

B cell development; Gene regulation; NK cells; Transcription factors

Indexed keywords

ANTIGEN; ATAXIN 1; CD160 ANTIGEN; CD244 ANTIGEN; EARLY B CELL FACTOR 1; KILLER CELL LECTIN LIKE RECEPTOR A7; PROTEIN; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; LIVER CELL; LYMPHOPOIESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIGENS, LY; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL LINEAGE; CELLS, CULTURED; GENE DOSAGE; KILLER CELLS, NATURAL; LYMPHOPOIESIS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PRECURSOR CELLS, B-LYMPHOID; TRANS-ACTIVATORS;

EID: 79957559436     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041137     Document Type: Article

References (30)

1. Davidson, E. H., The Regulatory Genome: Gene Regulatory Networks in Development and Evolution, Academic Press, San Diego, USA, 2006.
2. Nutt, S. L. and Kee, B. L., The transcriptional regulation of B cell lineage commitment. Immunity 2007. 26: 715-725.
3. Northrup, D. L. and Allman, D., Transcriptional regulation of early B cell development. Immunol. Res. 2008. 42: 106-117.
4. Seet, C. S., Brumbaugh, R. L. and Kee, B. L., Early B cell factor promotes B lymphopoiesis with reduced interleukin-7 responsiveness in the absence of E2A. J. Exp. Med. 2004. 199: 1689-1700.
5. Medina, K. L., Pongubala, J. M. R., Reddy, K. L., Lancki, D. W., DeKoter, R. P., Kieslinger, M., Grosschedl, R. and Singh, H., Defining a regulatory network for specification of the B cell fate. Dev. Cell 2004. 7: 607-617.
6. Dias, S., Silva, H., Jr., Cumano, A. and Viera, P., Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J. Exp. Med. 2005. 201: 971-979.
7. Kikuchi, K., Lai, A. Y., Hsu, C.-L. and Kondo, M., IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 2005. 201: 1197-1203.
8. Kikuchi, K., Kasai, H., Watanabe, A., Lai, A. Y. and Kondo, M., IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining Early B cell factor expression. J. Immunol. 2008. 181: 383-392.
9. Reynaud, D., Demarco, I. A., Reddy, K. L., Schjerven, H., Bertolino, E., Chen, Z., Smale, S. T. et al., Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 2008. 9: 927-936.
10. Pongubala, J. M., Northrup, D. L., Lancki, D. W., Medina, K. L., Treiber, T., Bertolino, E., Thomas, M. et al., Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat. Immunol. 2008. 9: 203-215.
11. Thal, M., Carvalho, T. L., He, T., Kim, H. G., Gao, H., Hagman, J. and Klug, C. A., Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc. Natl. Acad. Sci. USA 2009. 106: 552-557.
12. Treiber, T., Mandel, E. M., Pott, S., Gyory, I., Firner, S., Liu, E. T. and Grosschedl, R., Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription-independent poising of chromatin. Immunity 2010. 32: 714-725.
13. Lin, Y. C., Jhunjhunwala, S., Benner, C., Heinz, S., Welinder, E., Mansson, R., Sigvardsson, M. et al., A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 2010. 11: 635-643.
14. Maier, H., Ostraat, R., Gao, H., Fields, S., Shinton, S. A., Medina, K. L., Ikawa, T. et al., Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immun. 2004. 5: 1069-1077.
15. Lukin, K., Fields, S., Lopez, D., Cherrier, M., Ternyak, K., Ramirez, J., Feeney, A. J. and Hagman, J., Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression. Proc. Natl. Acad. Sci. USA 2010. 107: 7869-7874.
16. Rolink, A., ten Boekel, E., Melchers, F., Fearon, D. T., Krop, I. and Andersson, J., A subpopulation of B220+cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 1996. 183: 187-194.
17. Nutt, S. L., Heavey, B., Rolink, A. G. and Busslinger, M., Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999. 401: 556-562.
18. Rosmaraki, E. E., Douagi, I., Roth, C., Colucci, F., Cumano, A. and Di Santo, J. P., Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 2001. 31: 1900-1909.
19. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. and Morrison, S. J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005. 121: 1109-1121.
20. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 1991. 173: 1213-1225.
21. Hardy, R. R., Kincade, P. W. and Dorshkind, K., The protean nature of cells in the B lymphocyte lineage. Immunity 2007. 26: 703-714.
22. Boos, M. D., Yokota, Y., Eberl, G. and Kee, B. L., Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 2007. 204: 1119-1130.
23. Gascoyne, D. M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O., Seddon, B., Coles, M. et al., The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009. 10: 1118-1124.
24. Kozmik, Z., Wang, S., Dorfler, P., Adams, B. and Busslinger, M., The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 1992. 12: 2662-2672.
25. Fitzsimmons, D., Hodsdon, W., Wheat, W., Maira, S.-M., Wasylyk, B. and Hagman, J., Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B cell-specific promoter. Genes Dev. 1996. 10: 2198-2211.
26. Mikkola, I., Heavey, B., Horcher, M. and Busslinger, M., Reversion of B cell commitment upon loss of Pax5 expression. Science 2002. 297: 110-113.
27. Kamath, M. B., Houston, I. B., Janovski, A. J., Zhu, X., Gowrisankar, S., Jegga, A. G. and DeKoter, R. P., Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity. Leukemia 2008. 22: 1214-1225.
28. Bradfute, S. B., Graubert, T. A. and Goodell, M. A., Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp. Hematol. 2005. 33: 836-843.
29. Qian, W. and Zhang, J., Gene dosage and gene duplicability. Genetics 2008. 179: 2319-2324.
30. Månsson, R., Zandi, S., Welinder, E., Tsapogas, P., Sakaguchi, N., Bryder, D. and Sigvardsson, M., Single-cell analysis of the common lymphoid progenitor compartment reveals functional and molecular heterogeneity. Blood 2010. 115: 2601-2609.